Hong Kong listed Innovent Biologics gains around 20% on trading debut
Date: 2018-11-01   Author: Pankaj Singh  Category: #news

Hong Kong listed Innovent Biologics gains around 20% on trading debut

Biopharmaceutical technology firm Innovent Biologics surged about 20 percent after it debuted in the Hong Kong market, which was closely being observed to see the interest of investors in Chinese biotechs, as three of its competitors had previously experienced a slide in their shares post post-listing. The biotech firm, which is backed by Singapore state investor Temasek Holdings and mutual fund giant Fidelity, evidently closed 18.6 percent above its IPO price of HK$13.98, at HK$16.58.

Director at broker UOB Kay Hian, Steven Leung, said that this strong debut can be seen as a one-timer , with the rebound in the broader market being a major reason for this and it still does not indicate a return of interest to the IPO market. The Hang Seng Index had closed with 1.6 percent gain on the same day.

The listing of Innovent, aimed at wooing early-stage drug developers, was the fourth under new rules in Hong Kong. The company has supposedly raised $421 million, which made it the biggest Hong Kong biotech offering of this year.

The new rules implemented by Hong Kong seemingly allowed the biotech corporations with no profit or revenue to be listed in the city in April, in an attempt to persuade new-economy firms away from centers like New York.

The first biotech firm to debut under the new rules was Ascletis Pharma, which has plunged about 60 per cent since it got listed on August 1. Another firm, Hua Medicine, plummeted 17 per cent since its debut on September 14. BeiGene Ltd., that was listed on Nasdaq already, has lost 37 per cent of its value since its August 8 debut, while the benchmark Hang Seng Index is down by 13 percent since August.

Analysts and bankers have said that nine other biotechs which include WuXi AppTech Co. Ltd. and Ascentage Pharma have filed for Hong Kong listings, but the wider market jitters and poor performance of deals so far have obscured those prospects.



About Author


Pankaj Singh

Pankaj Singh

Pankaj Singh Develops content for Algosonline, Market Size Forecasters, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

Read More

More from Pankaj


Post Recommendents

Earned Value Management Software Market Future Challenges and Industry Growth Outlook 2025
Author: Sachin Pashte

Market Study Report LLC delivers significant information and realistic data of the Global Earned Value Management Software Market via this newly added research in its database. The report presents a deep study of the market growth factors and driv...


Global Data Center Monitoring Software Market Size, Analytical Overview, Growth Factors, Demand, Trends and Forecast to 2025
Author: Sachin Pashte

MarketStudyReport.com adds New Report on Global Data Center Monitoring Software Market to its research database. The report focuses on global major leading players with information such as company profiles, Growth, product segment, technology segm...


Automotive Wire & Cable Market by Trends, Key Players, Driver, Segmentation, Forecast to 2025
Author: Sachin Pashte

The latest report on ' Automotive Wire & Cable Market' now available at Market Study Report, LLC, explains the current and upcoming trends besides details related to the regional landscape of the ' Automotive Wire & Cable marke...